CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE
Clinical trials for CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a Plant-Based pill help lung damage from autoimmune disease?
Disease control Recruiting nowThis study tests whether tetrandrine tablets can improve lung function in adults with interstitial lung disease caused by connective tissue disease (like lupus or scleroderma). About 100 participants will take either tetrandrine or a placebo for 24 weeks, alongside their usual me…
Matched conditions: CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE
Phase: PHASE4 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
Engineered immune cells aim to tame childhood autoimmune diseases
Disease control Recruiting nowThis study tests a new treatment using specially engineered immune cells (CAR-NK cells) in children aged 5 and older with severe rheumatic diseases like lupus that have not responded to standard therapies. The cells are designed to target and destroy faulty immune cells that caus…
Matched conditions: CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated May 12, 2026 13:41 UTC